Author

S. Jeyasankar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

R. Agarwal· 3 shared A. A. Dravid· 2 shared A. Goswami· 2 shared P. R. Sharma· 2 shared A. P. S.· 1 shared E. George· 1 shared G. V. G. Kolluru· 1 shared I. Gauttam· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

R. Agarwal

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Lung-mimicking 3-Dimensional hydrogel culture system recapitulates key tuberculosis phenotypes and demonstrates pyrazinamide efficacy

G. V. G. Kolluru, A. P. S., V. Vaishnavi V., J. K. M., S. Jeyasankar, V. Raghunathan, R. Agarwal

This paper develops a 3D hydrogel culture system that mimics lung tissue and reproduces key tuberculosis phenotypes, demonstrating the efficacy of pyrazinamide.

Advanced Healthcare Materials · May 1, 2024Peer-reviewedBioengineering

Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles

E. George, A. Goswami, T. Lodhiya, P. Padwal, S. Iyer, I. Gauttam, L. Sethi, S. Jeyasankar, P. R. Sharma, A. A. Dravid, R. Mukherjee, R. Agarwal

This study develops OMV-AuNP as a stabilized TB vaccine candidate showing enhanced immune activation through TLR2 and TLR4.

bioRxiv · Jun 7, 2022Bioengineering

Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages

P. R. Sharma, A. A. Dravid, Y. K. Chakravarthy, V. K. Gupta, S. Jeyasankar, A. Goswami, R. Agarwal

This study shows cationic inhalable microparticles enhance drug delivery to Mtb-infected macrophages, improving anti-bacterial function and uptake in vitro and in mice lungs.

bioRxiv · Dec 1, 2021Bioengineering